Vol 5, No 2 (April 22, 2016): Translational Cancer Research

Immunologic response of combined interleukin-2 and stereotactic body radiotherapy

Potential value of immunoscoring in rectal cancer patients

Non-surgical treatment for locally advanced head and neck squamous cell carcinoma: beyond the upper limit

Epidermal growth factor-like repeats and discoidin I-like domains 3: a multifaceted oncoprotein at the crossroad of MAPK and TGF-beta pathways in human hepatocellular carcinoma

Skipping the line: bringing MET exon 14 skipping mutations to the forefront of targeted therapy

Quality of life versus survival benefits in patients with HER-2 negative metastatic gastric cancer: exploration of the randomized trials from the patient’s perspective

Bevacizumab in pleural mesothelioma: too few, too late?

The French initiative paves the way: routine molecular profiling of advanced non-small-cell lung cancer fights inequalities in access to molecular targeted therapy and improves patient outcome

TIME for biomarker-driven immunotherapy in non-small-cell lung cancer patients

OSMR and SEPT9: promising biomarkers for detection of colorectal cancer based on blood-based tests

miR-17 enhances proliferation and migration and inhibits apoptosis in glioma cells by regulating SASH1 expression

Contrast enhanced ultrasound guided biopsy shows higher positive sampling rate than conventional ultrasound guided biopsy for gastrointestinal stromal tumors diagnosis

Low correlation of lncRNA and target gene expression in microarray data

Overexpression of methylation-driven DCC suppresses proliferation of lung cancer cells

Applying gene set analysis to characterize the activities of immune cells in estrogen receptor positive breast cancer

A case of tuberculum sellae meningioma with “beak of Kiwi bird” enhancement in MRI: surgical resection and nursing care

Optimizing radiation for cancer immunotherapy

CD8⁺ T effector targeted elimination of regulatory tumor stroma cells for improved immunotherapy

Hypoxic cell sensitization in chemoradiation for cervical cancer

Anti-epidermal growth factor receptor immunotherapy in combination with cisplatin chemoradiation for patients with advanced head and neck carcinoma—biological and clinical limitations of the triple treatment

Expanding opportunities for crizotinib resistance in ALK-positive lung cancer patients

Clinomics—an underutilized resource?

Epithelial-mesenchymal transition as a potential biomarker for identifying responders to immune checkpoint inhibitor therapy in lung adenocarcinoma

Value of correlative biomarkers in understanding tumor biology

Notch signaling and Tp53/RB1 pathway in pulmonary neuroendocrine tumorigenesis